Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Hannah Daniel

Reporter

Hannah joined Medtech Insight from HBW Insight in August 2022 and reports on cybersecurity, patent law and other facets of medical device regulation. Hannah is passionate about the intersection of science and communication and holds a bachelor’s degree in biology from Carnegie Mellon University.

Latest From Hannah Daniel

FDA Encourages Voluntary Device Shortage Reporting After PHE End

The FDA updated its policies regarding 506J notifications for device manufacturers at the end of the public health emergency.

Coronavirus COVID-19 FDA

Digital Health Roundup: HIMSS, Cardio Conversations, ChatGPT And New FDA Guidances

In this month’s Digital Health Roundup, Medtech Insight’s Marion Webb discusses how two medtech CEOs are and aren’t using ChatGPT in their businesses while Reed Miller talks about his “Cardio Conversations” podcast interviews with Quentin Blackford, CEO of iRhythm, and Rob Krummen, CEO of Vektor Medical. Washington, DC-based reporter Hannah Daniel reviews highlights from the HIMSS conference and the latest updates on FDA guidances.

Artificial Intelligence Business Strategies

FDA, CDER Discuss AI/ML In Drug Development In Discussion Papers

FDA hopes to engage in “mutual learning” with stakeholders to develop new regulations for the use of AI/ML drug development.

FDA Artificial Intelligence

Industry Leaders Urge Congress, CMS To Expand Coverage Of Breakthrough Devices

Medtech leaders urged Congress to ensure coverage of breakthrough devices during a hearing by the House Ways and Means Subcommittee on Health.

Medicaid Medicare

News We’re Watching: Cancer Screening Partnership, New Abbott Electrophysiology Head, V-Champs AI Challenge

This week, Bioventus announced plans to sell its wound business; Pfizer and Thermo Fisher Scientific partnered to increase cancer screening access; and the FDA expanded the magnetic resonance imaging labeling for Abbott’s Eterna spinal cord stimulator.

Commercial Regulation

‘We Need More Time‘: Medtech Groups Testify Before EPA On ETO Emissions Regulation

Medtech groups call for extended commentary and compliance periods for two new EtO regulations from the EPA. 

Policy Companies
See All
UsernamePublicRestriction

Register